229 related articles for article (PubMed ID: 31571630)
1. Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA.
Rather RA; Dhawan V; Saha SC
Indian J Med Res; 2019 Jul; 150(1):62-66. PubMed ID: 31571630
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
3. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis.
Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V
Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women.
Darlington M; Carbonne B; Mailloux A; Brossard Y; Levy-Mozziconacci A; Cortey A; Maoulida H; Simon T; Rousseau A; Durand-Zaleski I;
BMC Pregnancy Childbirth; 2018 Dec; 18(1):496. PubMed ID: 30547830
[TBL] [Abstract][Full Text] [Related]
5. Genotyping approach for non-invasive foetal RHD detection in an admixed population.
Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM
Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy.
Vivanti A; Benachi A; Huchet FX; Ville Y; Cohen H; Costa JM
Am J Obstet Gynecol; 2016 Nov; 215(5):606.e1-606.e5. PubMed ID: 27393271
[TBL] [Abstract][Full Text] [Related]
7. Algorithm development and diagnostic accuracy testing for non-invasive foetal RHD genotyping: an Indian experience.
Parchure D; Madkaikar M; Kulkarni S
Blood Transfus; 2022 May; 20(3):235-244. PubMed ID: 33819144
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma.
Wang XD; Wang BL; Ye SL; Liao YQ; Wang LF; He ZM
Eur J Clin Invest; 2009 Jul; 39(7):607-17. PubMed ID: 19545247
[TBL] [Abstract][Full Text] [Related]
9. RHD exon 5, 7 and 10 targeted non-invasive prenatal screening of fetal Rhesus-D (RhD) in selected RhD negative pregnant women in Ethiopia.
Niguse B; Ermias M; Berhanu S; Abayneh L; Chakiso B; Rather RA
PLoS One; 2022; 17(3):e0265583. PubMed ID: 35298554
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.
Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M
BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548
[TBL] [Abstract][Full Text] [Related]
11. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
12. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
13. Confirmed non-invasive prenatal testing for foetal Rh blood group genotyping along with bi-allelic short insertion/deletion polymorphisms as a positive internal control.
Armstrong-Fisher S; Koushki K; Mashayekhi K; Urbaniak SJ; van der Schoot E; Varzi AM
Transfus Med; 2022 Apr; 32(2):141-152. PubMed ID: 35261100
[TBL] [Abstract][Full Text] [Related]
14. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia.
Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A
Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of non-invasive prenatal RHD genotyping of the fetus.
Hyland CA; Gardener GJ; Davies H; Ahvenainen M; Flower RL; Irwin D; Morris JM; Ward CM; Hyett JA
Med J Aust; 2009 Jul; 191(1):21-5. PubMed ID: 19580531
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
17. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women.
Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y
Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639
[TBL] [Abstract][Full Text] [Related]
18. Optimization of diagnostic strategy for non-invasive cell-free foetal RHD determination from maternal plasma.
Pazourkova E; Zednikova I; Korabecna M; Kralova J; Pisacka M; Novotna M; Calda P; Horinek A
Vox Sang; 2021 Oct; 116(9):1012-1019. PubMed ID: 33761162
[TBL] [Abstract][Full Text] [Related]
19. Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience.
Sbarsi I; Isernia P; Montanari L; Badulli C; Martinetti M; Salvaneschi L
Blood Transfus; 2012 Jan; 10(1):34-8. PubMed ID: 22153691
[TBL] [Abstract][Full Text] [Related]
20. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
